| scholarly article | Q13442814 |
| P50 | author | Michael A. Jarvis | Q42424922 |
| P2093 | author name string | Jay A Nelson | |
| David C Johnson | |||
| Michael A Jarvis | |||
| Derek D Drummond | |||
| Brent J Ryckman | |||
| P2860 | cites work | Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted | Q24655638 |
| Roles for Endocytosis and Low pH in Herpes Simplex Virus Entry into HeLa and Chinese Hamster Ovary Cells | Q24679497 | ||
| On the entry of Semliki forest virus into BHK-21 cells | Q27482326 | ||
| An efficient recombination system for chromosome engineering in Escherichia coli | Q29615038 | ||
| Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion | Q36877928 | ||
| Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence | Q37422612 | ||
| Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome | Q37568012 | ||
| Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain | Q37593516 | ||
| Mutations in herpes simplex virus glycoprotein D distinguish entry of free virus from cell-cell spread | Q39593535 | ||
| Human cytomegalovirus infection of caco-2 cells occurs at the basolateral membrane and is differentiation state dependent | Q39593923 | ||
| Herpes simplex virus gE/gI sorts nascent virions to epithelial cell junctions, promoting virus spread | Q39601524 | ||
| Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells | Q39869648 | ||
| Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. | Q39872953 | ||
| Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes | Q39960937 | ||
| Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration | Q40107079 | ||
| Infectious cell entry mechanism of influenza virus. | Q40141916 | ||
| Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus | Q40727982 | ||
| Cell types involved in replication and distribution of human cytomegalovirus. | Q40958077 | ||
| Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface | Q41597223 | ||
| Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism | Q41839444 | ||
| Entry of human cytomegalovirus into retinal pigment epithelial and endothelial cells by endocytosis | Q41923033 | ||
| Penetration of cells by herpes simplex virus does not require a low pH-dependent endocytic pathway | Q41942419 | ||
| Pathway of vesicular stomatitis virus entry leading to infection | Q43674816 | ||
| Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate | Q46056201 | ||
| Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance | Q46657547 | ||
| Genetic content of wild-type human cytomegalovirus | Q47709383 | ||
| Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells | Q57275307 | ||
| Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy | Q71210092 | ||
| Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus | Q73209433 | ||
| Nuclear import as a barrier to infection of human umbilical vein endothelial cells by human cytomegalovirus strain AD169 | Q77447839 | ||
| Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease | Q78052127 | ||
| A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA | Q29615197 | ||
| Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells | Q33661004 | ||
| Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1. | Q33788855 | ||
| Human cytomegalovirus cell-to-cell spread in the absence of an essential assembly protein | Q33837853 | ||
| Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway | Q33843108 | ||
| Human cytomegalovirus UL130 protein promotes endothelial cell infection through a producer cell modification of the virion. | Q33843302 | ||
| Poly(ethylene glycol) (PEG)-mediated fusion between pure lipid bilayers: a mechanism in common with viral fusion and secretory vesicle release? | Q33892321 | ||
| Deletion of gpUL132, a structural component of human cytomegalovirus, results in impaired virus replication in fibroblasts | Q33987451 | ||
| A review of genetic differences between limited and extensively passaged human cytomegalovirus strains | Q34263661 | ||
| Directed egress of animal viruses promotes cell-to-cell spread | Q34327423 | ||
| Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry | Q34344174 | ||
| The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics | Q34345137 | ||
| Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread. | Q34364995 | ||
| Coding potential of laboratory and clinical strains of human cytomegalovirus | Q34388908 | ||
| Do pathogens accelerate atherosclerosis? | Q34389205 | ||
| Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus | Q34535736 | ||
| Rapid genetic engineering of human cytomegalovirus by using a lambda phage linear recombination system: demonstration that pp28 (UL99) is essential for production of infectious virus. | Q34553401 | ||
| Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence | Q35111605 | ||
| Cellular and viral requirements for rapid endocytic entry of herpes simplex virus | Q35122489 | ||
| The human cytomegalovirus. | Q35143349 | ||
| Microtubule network facilitates nuclear targeting of human cytomegalovirus capsid | Q35155425 | ||
| Herpesvirus entry: an update | Q35217323 | ||
| Pathogenesis of human cytomegalovirus infection and cellular targets | Q35789320 | ||
| Endocytosis of influenza viruses | Q35862726 | ||
| Integrin alphavbeta3 is a coreceptor for human cytomegalovirus | Q35865693 | ||
| Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity | Q36495307 | ||
| Correlation between infectivity and physical virus particles in human cytomegalovirus | Q36510535 | ||
| A herpes simplex virus 1 US11-expressing cell line is resistant to herpes simplex virus infection at a step in viral entry mediated by glycoprotein D | Q36633169 | ||
| Envelope glycoprotein gp50 of pseudorabies virus is essential for virus entry but is not required for viral spread in mice | Q36639085 | ||
| A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H | Q36686818 | ||
| Epstein-Barr virus enters B cells and epithelial cells by different routes | Q36697940 | ||
| Entry of herpes simplex virus 1 in BJ cells that constitutively express viral glycoprotein D is by endocytosis and results in degradation of the virus | Q36825917 | ||
| A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells | Q36866557 | ||
| Herpes simplex viruses lacking glycoprotein D are unable to inhibit virus penetration: quantitative evidence for virus-specific cell surface receptors | Q36873841 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cytomegalovirus | Q6946 |
| endothelium | Q111140 | ||
| P304 | page(s) | 710-722 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion | |
| P478 | volume | 80 |
| Q36069719 | A Homolog Pentameric Complex Dictates Viral Epithelial Tropism, Pathogenicity and Congenital Infection Rate in Guinea Pig Cytomegalovirus |
| Q37182670 | A Novel Non-Replication-Competent Cytomegalovirus Capsid Mutant Vaccine Strategy Is Effective in Reducing Congenital Infection |
| Q40060063 | A comparative review of viral entry and attachment during large and giant dsDNA virus infections. |
| Q91675842 | A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection |
| Q33648958 | A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells |
| Q35378089 | A viral regulator of glycoprotein complexes contributes to human cytomegalovirus cell tropism. |
| Q37127280 | An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model |
| Q36667906 | An endothelial cell-specific requirement for the UL133-UL138 locus of human cytomegalovirus for efficient virus maturation |
| Q91264520 | Analysis of relationships between polymorphisms in the genes encoding the pentameric complex and neutralization of clinical cytomegalovirus isolates |
| Q28550400 | Antigenic Characterization of the HCMV gH/gL/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human Antibodies |
| Q21559401 | BST2/Tetherin enhances entry of human cytomegalovirus |
| Q54217767 | CD147 Promotes Entry of Pentamer-Expressing Human Cytomegalovirus into Epithelial and Endothelial Cells. |
| Q37347325 | Cell Surface THY-1 Contributes to Human Cytomegalovirus Entry via a Macropinocytosis-Like Process |
| Q42572343 | Characterization of a discontinuous neutralizing epitope on glycoprotein B of human cytomegalovirus |
| Q45942829 | Characterization of the guinea pig cytomegalovirus genome locus that encodes homologs of human cytomegalovirus major immediate-early genes, UL128, and UL130. |
| Q36423984 | Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. |
| Q39943786 | Charge cluster-to-alanine scanning of UL128 for fine tuning of the endothelial cell tropism of human cytomegalovirus |
| Q40067378 | Chemokines encoded by herpesviruses |
| Q63246525 | Chewing the Fat: The Conserved Ability of DNA Viruses to Hijack Cellular Lipid Metabolism |
| Q36685041 | Coding potential of UL/b' from the initial source of rhesus cytomegalovirus Strain 68-1. |
| Q37123419 | Comparative analysis of gO isoforms reveals that strains of human cytomegalovirus differ in the ratio of gH/gL/gO and gH/gL/UL128-131 in the virion envelope |
| Q37406553 | Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis |
| Q37336684 | Contributions of herpes simplex virus 1 envelope proteins to entry by endocytosis |
| Q33557172 | Cytomegalovirus Restructures Lipid Rafts via a US28/CDC42-Mediated Pathway, Enhancing Cholesterol Efflux from Host Cells |
| Q40145257 | Cytomegalovirus UL128 homolog mutants that form a pentameric complex produce virus with impaired epithelial and trophoblast cell tropism and altered pathogenicity in the guinea pig. |
| Q41786108 | Cytomegalovirus UL131-128 products promote gB conformational transition and gB-gH interaction during entry into endothelial cells |
| Q37559627 | Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation |
| Q27000998 | Cytomegalovirus antivirals and development of improved animal models |
| Q37252609 | Cytomegalovirus vaccine strain towne-derived dense bodies induce broad cellular immune responses and neutralizing antibodies that prevent infection of fibroblasts and epithelial cells |
| Q36517096 | Cytomegalovirus vaccines and methods of production (WO20009049138): the emerging recognition of the importance of virus neutralization at the epithelial/endothelial interface |
| Q36973592 | Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection |
| Q33351523 | Cytomegalovirus: pathogen, paradigm, and puzzle |
| Q37574334 | Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next? |
| Q36757818 | Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies |
| Q58598607 | Development of a primary human cell model for the study of human cytomegalovirus replication and spread within salivary epithelium |
| Q90271787 | Development of novel vaccines against human cytomegalovirus |
| Q92890550 | Differential Expression of PDGF Receptor-α in Human Placental Trophoblasts Leads to Different Entry Pathways by Human Cytomegalovirus Strains |
| Q38741498 | Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression. |
| Q91198936 | Distribution of the CMV glycoprotein gH/gL/gO and gH/gL/pUL128/pUL130/pUL131A complex variants and associated clinical manifestations in infants infected congenitally or postnatally |
| Q37997733 | Diverse immune evasion strategies by human cytomegalovirus |
| Q57039007 | Dynamin is required for efficient cytomegalovirus maturation and envelopment |
| Q37875379 | Early inhibitors of human cytomegalovirus: state-of-art and therapeutic perspectives |
| Q37018933 | Efficient replication of rhesus cytomegalovirus variants in multiple rhesus and human cell types |
| Q95661029 | Enhancement of guinea pig cytomegalovirus infection by two endogenously expressed components of the pentameric glycoprotein complex in epithelial cells |
| Q42220221 | Entry of human cytomegalovirus into porcine endothelial cells depends on both the cellular vascular origin and the viral strain |
| Q54216733 | Expression levels of glycoprotein O (gO) vary between strains of human cytomegalovirus, influencing the assembly of gH/gL complexes and virion infectivity. |
| Q38793250 | Expression of Oncogenic Alleles Induces Multiple Blocks to Human Cytomegalovirus Infection |
| Q40178622 | Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans. |
| Q90600086 | First Impressions-the Potential of Altering Initial Host-Virus Interactions for Rational Design of Herpesvirus Vaccine Vectors |
| Q37519151 | Functional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope protein |
| Q38796870 | Genetic Stability of Bacterial Artificial Chromosome-Derived Human Cytomegalovirus during Culture In Vitro. |
| Q38411353 | Genetic variability of cytomegalovirus glycoprotein O in hematopoietic stem cell transplant recipients |
| Q33918304 | Glycoprotein B switches conformation during murid herpesvirus 4 entry |
| Q36517126 | Guinea Pig Cytomegalovirus (GPCMV): A Model for the Study of the Prevention and Treatment of Maternal-Fetal Transmission |
| Q98461001 | Guinea pig cytomegalovirus trimer complex gH/gL/gO uses PDGFRA as universal receptor for cell fusion and entry |
| Q40877837 | HCMV Induces Macropinocytosis for Host Cell Entry in Fibroblasts |
| Q36501775 | HCMV gB shares structural and functional properties with gB proteins from other herpesviruses. |
| Q36893722 | HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors |
| Q37673149 | HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex |
| Q33798083 | HCMV spread and cell tropism are determined by distinct virus populations |
| Q64235200 | HCMV trimer- and pentamer-specific antibodies synergize for virus neutralization but do not correlate with congenital transmission |
| Q89554848 | Herpes Simplex Virus Glycoprotein C Regulates Low-pH Entry |
| Q34285628 | Herpes virus fusion and entry: a story with many characters. |
| Q33727577 | Herpesvirus Entry into Host Cells Mediated by Endosomal Low pH. |
| Q26774203 | Herpesvirus gB: A Finely Tuned Fusion Machine |
| Q26863328 | Herpesviruses and intermediate filaments: close encounters with the third type |
| Q37436158 | Heterogeneous pathways of maternal-fetal transmission of human viruses (review). |
| Q40653356 | Host protein Snapin interacts with human cytomegalovirus pUL130 and affects viral DNA replication |
| Q36535574 | Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins |
| Q92127331 | Human Cytomegalovirus Cell Tropism and Host Cell Receptors |
| Q92225749 | Human Cytomegalovirus Enters the Primary CD34+ Hematopoietic Progenitor Cells Where It Establishes Latency by Macropinocytosis |
| Q39100413 | Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells. |
| Q35745418 | Human Cytomegalovirus UL135 and UL136 Genes Are Required for Postentry Tropism in Endothelial Cells |
| Q35991173 | Human Cytomegalovirus gH/gL Forms a Stable Complex with the Fusion Protein gB in Virions |
| Q35913890 | Human Cytomegalovirus gH/gL/gO Promotes the Fusion Step of Entry into All Cell Types, whereas gH/gL/UL128-131 Broadens Virus Tropism through a Distinct Mechanism |
| Q38732318 | Human Cytomegalovirus miR-UL148D Facilitates Latent Viral Infection by Targeting Host Cell Immediate Early Response Gene 5. |
| Q38753357 | Human Cytomegalovirus nuclear egress and secondary envelopment are negatively affected in the absence of cellular p53. |
| Q84974854 | Human Cytomegalovirus: Propagation, Quantification, and Storage |
| Q36936292 | Human cytomegalovirus (HCMV) glycoprotein gB promotes virus entry in trans acting as the viral fusion protein rather than as a receptor-binding protein |
| Q33649006 | Human cytomegalovirus TR strain glycoprotein O acts as a chaperone promoting gH/gL incorporation into virions but is not present in virions |
| Q36325778 | Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue |
| Q37431029 | Human cytomegalovirus entry into cells |
| Q34230355 | Human cytomegalovirus entry into dendritic cells occurs via a macropinocytosis-like pathway in a pH-independent and cholesterol-dependent manner |
| Q36741322 | Human cytomegalovirus gH stability and trafficking are regulated by ER-associated degradation and transmembrane architecture |
| Q92709054 | Human cytomegalovirus glycoprotein B variants affect viral entry, cell fusion, and genome stability |
| Q35531288 | Human cytomegalovirus glycoprotein gO complexes with gH/gL, promoting interference with viral entry into human fibroblasts but not entry into epithelial cells |
| Q36974741 | Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans |
| Q36232248 | Human cytomegalovirus induction of a unique signalsome during viral entry into monocytes mediates distinct functional changes: a strategy for viral dissemination |
| Q37967568 | Human cytomegalovirus infection and atherothrombosis |
| Q41909075 | Human cytomegalovirus infection of langerhans-type dendritic cells does not require the presence of the gH/gL/UL128-131A complex and is blocked after nuclear deposition of viral genomes in immature cells |
| Q35780389 | Human cytomegalovirus is protected from inactivation by reversible binding to villous trophoblasts |
| Q36363329 | Human cytomegalovirus pUL78 G protein-coupled receptor homologue is required for timely cell entry in epithelial cells but not fibroblasts |
| Q36587164 | Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal |
| Q34422068 | Human cytomegalovirus tropism for mucosal myeloid dendritic cells |
| Q36289031 | Human cytomegalovirus uses two distinct pathways to enter retinal pigmented epithelial cells |
| Q21089588 | Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex |
| Q38430703 | Human cytomegalovirus: taking the strain |
| Q24635001 | Human herpesvirus 6 glycoprotein complex formation is required for folding and trafficking of the gH/gL/gQ1/gQ2 complex and its cellular receptor binding |
| Q37772887 | Human herpesvirus-6 entry into host cells |
| Q41773417 | Identification by mass spectrometry and immune response analysis of guinea pig cytomegalovirus (GPCMV) pentameric complex proteins GP129, 131 and 133. |
| Q34992770 | Identification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus |
| Q92252211 | Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection |
| Q37252891 | Impact of sequence variation in the UL128 locus on production of human cytomegalovirus in fibroblast and epithelial cells |
| Q30832341 | Importance of Highly Conserved Peptide Sites of Human Cytomegalovirus gO for Formation of the gH/gL/gO Complex |
| Q36208168 | Inactivation of the Human Cytomegalovirus US20 Gene Hampers Productive Viral Replication in Endothelial Cells |
| Q36146446 | Infection and upregulation of proinflammatory cytokines in human brain vascular pericytes by human cytomegalovirus |
| Q36736886 | Infection of a Single Cell Line with Distinct Strains of Human Cytomegalovirus Can Result in Large Variations in Virion Production and Facilitate Efficient Screening of Virus Protein Function |
| Q36414448 | Infection of vascular endothelial cells with human cytomegalovirus under fluid shear stress reveals preferential entry and spread of virus in flow conditions simulating atheroprone regions of the artery |
| Q38838830 | Inhibition of endocytic pathways impacts cytomegalovirus maturation. |
| Q34708600 | Intravaginal cytomegalovirus (CMV) challenge elicits maternal viremia and results in congenital transmission in a guinea pig model |
| Q38711117 | Loss of the Human Cytomegalovirus US16 Protein Abrogates Virus Entry into Endothelial and Epithelial Cells by Reducing the Virion Content of the Pentamer. |
| Q33769277 | Low pH-induced conformational change in herpes simplex virus glycoprotein B. |
| Q35382962 | Low-pH-dependent changes in the conformation and oligomeric state of the prefusion form of herpes simplex virus glycoprotein B are separable from fusion activity |
| Q27683850 | Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109 |
| Q35599273 | Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture |
| Q38257810 | Models of vertical cytomegalovirus (CMV) transmission and pathogenesis |
| Q41786247 | Mutational mapping of UL130 of human cytomegalovirus defines peptide motifs within the C-terminal third as essential for endothelial cell infection |
| Q39451875 | Mutational mapping of pUL131A of human cytomegalovirus emphasizes its central role for endothelial cell tropism |
| Q54254744 | Navigating the Host Cell Response during Entry into Sites of Latent Cytomegalovirus Infection. |
| Q47167247 | Neutralization of Human Cytomegalovirus Entry into Fibroblasts and Epithelial Cells |
| Q42284197 | Neutralizing antibodies are unable to inhibit direct viral cell-to-cell spread of human cytomegalovirus |
| Q64890257 | Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response. |
| Q63246311 | OR14I1 is a receptor for the human cytomegalovirus pentameric complex and defines viral epithelial cell tropism |
| Q41881987 | Onset of human cytomegalovirus replication in fibroblasts requires the presence of an intact vimentin cytoskeleton |
| Q35076699 | Open reading frames carried on UL/b' are implicated in shedding and horizontal transmission of rhesus cytomegalovirus in rhesus monkeys. |
| Q34426442 | PDGF receptor-α does not promote HCMV entry into epithelial and endothelial cells but increased quantities stimulate entry by an abnormal pathway |
| Q60960757 | Pathogen at the Gates: Human Cytomegalovirus Entry and Cell Tropism |
| Q91219173 | Pathogen interactions with endothelial cells and the induction of innate and adaptive immunity |
| Q34885758 | Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells |
| Q37032510 | Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer |
| Q40330182 | Pneumonitis in human cytomegalovirus infection |
| Q36286850 | Polyethylene glycol-mediated fusion of herpes simplex type 1 virions with the plasma membrane of cells that support endocytic entry |
| Q36812617 | Preventing Congenital Cytomegalovirus Infection: Protection to a 'T'. |
| Q37409233 | Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers |
| Q42081310 | Protein pUL128 of human cytomegalovirus is necessary for monocyte infection and blocking of migration |
| Q39714762 | RASCAL is a new human cytomegalovirus-encoded protein that localizes to the nuclear lamina and in cytoplasmic vesicles at late times postinfection |
| Q54347426 | Rapid and accurate determination of the potency of varicella vaccine by quantitative polymerase chain reaction. |
| Q39304512 | Recombinant HCMV UL128 expression and functional identification of PBMC-attracting activity in vitro |
| Q34090187 | Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. |
| Q59349678 | Restriction of human cytomegalovirus infection by galectin-9 |
| Q57061992 | Role of PDGF receptor-α during human cytomegalovirus entry into fibroblasts |
| Q39336485 | Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis |
| Q33712506 | Role of the UL45 protein in herpes simplex virus entry via low pH-dependent endocytosis and its relationship to the conformation and function of glycoprotein B |
| Q35866191 | Scanning Mutagenesis of Human Cytomegalovirus Glycoprotein gH/gL. |
| Q34642568 | Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture |
| Q35090089 | Structural and biochemical studies of HCMV gH/gL/gO and Pentamer reveal mutually exclusive cell entry complexes |
| Q34317887 | Structural basis for the recognition of human cytomegalovirus glycoprotein B by a neutralizing human antibody |
| Q27487974 | Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme |
| Q28538007 | Systematic microRNA analysis identifies ATP6V0C as an essential host factor for human cytomegalovirus replication |
| Q37685690 | Technologies for Proteome-Wide Discovery of Extracellular Host-Pathogen Interactions |
| Q37183914 | Tegument proteins of human cytomegalovirus |
| Q40686811 | Tetraspanin CD151 Promotes Initial Events in Human Cytomegalovirus Infection |
| Q38837603 | Tetraspanins in infections by human cytomegalo- and papillomaviruses |
| Q40483485 | The D-form of a novel heparan binding peptide decreases cytomegalovirus infection in vivo and in vitro. |
| Q34819531 | The HCMV gH/gL/UL128-131 complex triggers the specific cellular activation required for efficient viral internalization into target monocytes |
| Q59354480 | The Human Cytomegalovirus Trimer and Pentamer Promote Sequential Steps in Entry into Epithelial and Endothelial Cells at Cell Surfaces and Endosomes |
| Q36878894 | The Human Cytomegalovirus UL116 Gene Encodes an Envelope Glycoprotein Forming a Complex with gH Independently from gL |
| Q37256740 | The M33 chemokine receptor homolog of murine cytomegalovirus exhibits a differential tissue-specific role during in vivo replication and latency. |
| Q37378850 | The Microtubule Inhibitor Podofilox Inhibits an Early Entry Step of Human Cytomegalovirus |
| Q92511027 | The N Terminus of Human Cytomegalovirus Glycoprotein O Is Important for Binding to the Cellular Receptor PDGFRα |
| Q36827232 | The ULb' region of the human cytomegalovirus genome confers an increased requirement for the viral protein kinase UL97. |
| Q36086685 | The US16 gene of human cytomegalovirus is required for efficient viral infection of endothelial and epithelial cells |
| Q38940024 | The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis |
| Q33609914 | The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus |
| Q40061531 | The infection of human primary cells and cell lines by human cytomegalovirus: new tropism and new reservoirs for HCMV. |
| Q40340374 | The m74 gene product of murine cytomegalovirus (MCMV) is a functional homolog of human CMV gO and determines the entry pathway of MCMV. |
| Q100762135 | The structural basis of herpesvirus entry |
| Q37296023 | The susceptibility of primary cultured rhesus macaque kidney epithelial cells to rhesus cytomegalovirus strains. |
| Q58327099 | The transcriptome of human mammary epithelial cells infected with the HCMV-DB strain displays oncogenic traits |
| Q38252422 | The use of microRNA by human viruses: lessons from NK cells and HCMV infection |
| Q34916655 | The viral chemokine MCK-2 of murine cytomegalovirus promotes infection as part of a gH/gL/MCK-2 complex |
| Q59356187 | There Is Always Another Way! Cytomegalovirus' Multifaceted Dissemination Schemes |
| Q36281094 | Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection |
| Q34742892 | Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques. |
| Q39502095 | Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies |
| Q37161687 | Viral binding-induced signaling drives a unique and extended intracellular trafficking pattern during infection of primary monocytes |
| Q26745798 | Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway |
| Q37146814 | gH/gL supercomplexes at early stages of herpesvirus entry |
Search more.